Covered recipient · General Payments record
LEONID KOL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$1,502.27
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $512.78 | 16 |
| Travel and Lodging | $48.02 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Nevro Corp. | $324.85 | 7 |
| SCILEX PHARMACEUTICALS INC. | $91.69 | 4 |
| ABBVIE INC. | $54.25 | 2 |
| Collegium Pharmaceutical, Inc. | $39.16 | 2 |
| FORTE BIO-PHARMA LLC | $25.79 | 1 |
| Valinor Pharma, LLC | $25.06 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.74 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107479566 | CMS |
| ABBVIE INC. | $30.51 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107479568 | CMS |
| Collegium Pharmaceutical, Inc. | $17.30 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135213888 | CMS |
| Collegium Pharmaceutical, Inc. | $21.86 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135329897 | CMS |
| Forte Bio-Pharma LLC | $25.79 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142424037 | CMS |
| Nevro Corp. | $40.80 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130762649 | CMS |
| Nevro Corp. | $48.02 | 03/17/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1130762655 | CMS |
| Nevro Corp. | $120.41 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130762831 | CMS |
| Nevro Corp. | $2.98 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130762659 | CMS |
| Nevro Corp. | $42.49 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130762661 | CMS |
| Nevro Corp. | $35.86 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130762653 | CMS |
| Nevro Corp. | $34.29 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130762651 | CMS |
| SCILEX PHARMACEUTICALS INC. | $24.26 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136220015 | CMS |
| SCILEX PHARMACEUTICALS INC. | $24.60 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136236473 | CMS |
| SCILEX PHARMACEUTICALS INC. | $19.12 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136241666 | CMS |
| SCILEX PHARMACEUTICALS INC. | $23.71 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136276776 | CMS |
| Valinor Pharma, LLC | $25.06 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130831862 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.